Create stable, long-term investment portfolio with strong, consistent stocks.
Start Research-backed Investing ...Now.
Ipca Laboratories is currently trading at Rs. 486.50, up by 13.45 points or 2.84% from its previous closing of Rs. 473.05 on the BSE.
The scrip opened at Rs. 470.45 and has touched a high and low of Rs. 489.90 and Rs. 470.25 respectively. So far 32380 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 495.00 on 01-Oct-2012 and a 52 week low of Rs. 245.00 on 19-Dec-2011.
Last one week high and low of the scrip stood at Rs. 494.55 and Rs. 443.00 respectively. The current market cap of the company is Rs. 6137.21 crore.
The promoters holding in the company stood at 45.91% while Institutions and Non-Institutions held 33.80% and 20.29% respectively.
Yes Bank has subscribed to IPCA Laboratories’ 200, 9.25% Secured, Redeemable Non Convertible Debentures of the face value of Rs 10 lakhs each, amounting to Rs 20 crore. These debentures will be redeemed in four equal installments of Rs 5 crore each beginning at the end of the second year from the date of allotment which is December 12, 2012. Further, these Non Convertible Debentures are proposed to be listed on the wholesale debt segment of the National Stock Exchange of India.
IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1462.50 |
| Dr. Reddys Lab | 5784.50 |
| Cipla | 1451.25 |
| Zydus Lifesciences | 1001.15 |
| Lupin | 1587.90 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
